What is it about?

Clinical observations demonstrated that COVID-19 related pneumonia is often accompanied by hematological and coagulation abnormalities including lymphopenia, thrombocytopenia, and prolonged prothrombin time. We suggest that C-reactive protein and prothrombin time levels present on admission in COVID-19 patients may be used as early prognostic markers of severe pneumonia requiring transfer to ICU.

Featured Image

Why is it important?

Clinical observations demonstrated that COVID-19 related pneumonia is often accompanied by hematological and coagulation abnormalities including lymphopenia, thrombocytopenia, and prolonged prothrombin time. The evaluation of laboratory findings including coagulation and inflammation parameters may represent a promising approach for early determination of COVID-19 severity.

Read the Original

This page is a summary of: Prolonged prothrombin time as an early prognostic indicator of severe acute respiratory distress syndrome in patients with COVID-19 related pneumonia, Current Medical Research and Opinion, December 2020, Taylor & Francis,
DOI: 10.1080/03007995.2020.1853510.
You can read the full text:

Read

Contributors

The following have contributed to this page